Imai Y, Oda H, Arai M, Shimizu S, Nakatsuru Y, Inoue T, Ishikawa T
Department of Pathology, Faculty of Medicine, University of Tokyo, Bunkyo-ku, Japan.
Jpn J Cancer Res. 1996 Oct;87(10):1056-62. doi: 10.1111/j.1349-7006.1996.tb03110.x.
Because combined hepatocellular-cholangiocellular carcinoma is rare and its biological features and pathogenesis have not been well established, we investigated alterations of the p53, K-ras and Rb-1 genes, as well as expression patterns of carcinoembryonic antigen and keratin, in seven combined hepatocellular-cholangiocarcinomas out of 557 hepatocellular carcinomas autopsied at Tokyo University during 30 years. Mutations of the p53 gene were found in two cases, at codon 244 (GGC to TGC) in the cholangiocellular carcinoma component of case 1 (mixed type, showing an intimate intermingling of both elements) and at codon 234 (TAC to AAC) in both components of case 5 (combined type, consisting of contiguous but independent masses of both elements). Mutation of the K-ras gene (codon 12, GGT to GAT) was seen only in the cholangiocellular carcinoma component of clinically apparent double cancer, case 6. Allelic alteration of the Rb-1 gene was observed in two cases, deletion of both alleles in the hepatocellular carcinoma component of case 3 (combined type) and replication error of the same pattern in both components of case 4 (mixed type). Immunohistochemical analysis showed that the hepatocellular carcinoma components of five cases (cases 2, 3, 5, 6, 7) were immunoreactive for keratin, suggesting biliary epithelial transformation. In four of the five cases (cases 3 and 5 combined, case 7 mixed and case 6 double cancer), cholangiocellular carcinoma components were also positive for keratin. These results suggest that both components of combined hepatocellular-cholangiocarcinoma have the same genetic and phenotypic character and might have arisen from the same origin in some cases.
由于肝内胆管癌合并肝细胞癌较为罕见,其生物学特性及发病机制尚未完全明确,我们对东京大学30年间尸检的557例肝细胞癌中的7例肝内胆管癌合并肝细胞癌进行了研究,检测了p53、K-ras和Rb-1基因的改变,以及癌胚抗原和角蛋白的表达模式。在2例病例中发现了p53基因突变,1号病例(混合型,两种成分紧密交织)的胆管细胞癌成分中密码子244(GGC突变为TGC)发生突变,5号病例(联合型,由两种成分相邻但独立的肿块组成)的两种成分中密码子234(TAC突变为AAC)发生突变。K-ras基因(密码子12,GGT突变为GAT)的突变仅见于临床诊断为双癌的6号病例的胆管细胞癌成分。在2例病例中观察到Rb-1基因的等位基因改变,3号病例(联合型)的肝细胞癌成分中两个等位基因均缺失,4号病例(混合型)的两种成分中出现相同模式的复制错误。免疫组化分析显示,5例病例(2、3、5、6、7号病例)的肝细胞癌成分对角蛋白呈免疫反应性,提示胆管上皮化生。在这5例病例中的4例(3号和5号病例联合、7号病例混合型和6号病例双癌),胆管细胞癌成分对角蛋白也呈阳性。这些结果表明,肝内胆管癌合并肝细胞癌的两种成分具有相同的遗传和表型特征,在某些情况下可能起源相同。